𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A Randomised Comparison of Bicalutamide (‘Casodex’) 150 mg versus Placebo as Immediate Therapy Either Alone or as Adjuvant to Standard Care for Early Non-Metastatic Prostate Cancer: First Report from the Scandinavian Prostatic Cancer Group Study No. 6

✍ Scribed by P Iversen; T.L.J Tammela; S Vaage; O Lukkarinen; P Lodding; T Bull-Njaa; J Viitanen; P Hoisaeter; P Lundmo; F Rasmussen; J.-E Johansson; B.-E Persson; K Carroll

Book ID
114218438
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
238 KB
Volume
42
Category
Article
ISSN
0302-2838

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bicalutamide as immediate therapy either
Bicalutamide as immediate therapy either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer: first analysis of the early prostate cancer program. See WA, Wirth MP, McLeod DG, Iversen P, Klimberg I, Gleason D, Chodak G, Montie J, Tyrrell C, Wallace DM, Delaere KP, Vaage S, Tammela TL, Lukkarinen O, Persson BE, Carroll K, Kolvenbag GJ; Casodex Early Prostate Cancer Trialist Group, Medical College of Wisconsin, Milwaukee, WI: J Urol 2002;168:429–435
✍ Donald L Trump 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 23 KB